AU2003291730A1 - Methods and compositions for treating neurodegenerative diseases - Google Patents

Methods and compositions for treating neurodegenerative diseases

Info

Publication number: AU2003291730A1
Authority: AU; Australia
Prior art keywords: compositions; methods; neurodegenerative diseases; treating neurodegenerative; treating
Prior art date: 2002-11-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003291730A

Other versions

AU2003291730A8 (en

Inventor

Claudio A. P. Joazeiro

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

IRM LLC

Original Assignee

IRM LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-04

Filing date

2003-11-04

Publication date

2004-06-07

2003-11-04 Application filed by IRM LLC filed Critical IRM LLC

2004-06-07 Publication of AU2003291730A8 publication Critical patent/AU2003291730A8/en

2004-06-07 Publication of AU2003291730A1 publication Critical patent/AU2003291730A1/en

Status Abandoned legal-status Critical Current

Links

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003291730A 2002-11-04 2003-11-04 Methods and compositions for treating neurodegenerative diseases Abandoned AU2003291730A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US42396102P	2002-11-04	2002-11-04
US60/423,961		2002-11-04
PCT/US2003/035106 WO2004041204A2 (en)	2002-11-04	2003-11-04	Methods and compositions for treating neurodegenerative diseases

Publications (2)

Publication Number	Publication Date
AU2003291730A8 AU2003291730A8 (en)	2004-06-07
AU2003291730A1 true AU2003291730A1 (en)	2004-06-07

Family

ID=32312728

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003291730A Abandoned AU2003291730A1 (en)	2002-11-04	2003-11-04	Methods and compositions for treating neurodegenerative diseases

Country Status (3)

Country	Link
US (1)	US20040171085A1 (en)
AU (1)	AU2003291730A1 (en)
WO (1)	WO2004041204A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050123970A1 (en) *	2001-04-25	2005-06-09	Can Ozbal	High throughput autosampler
US8414774B2 (en) *	2001-04-25	2013-04-09	Agilent Technologies, Inc.	Systems and methods for high-throughput screening of fluidic samples
GB2443819B (en) *	2003-11-17	2009-09-02	Univ Auburn	Methods and compositions for inhibiting intracellular aggregate formation
ES2547554T3 (en) *	2005-11-16	2015-10-07	Ambrx, Inc.	Methods and compositions comprising unnatural amino acids
CA2703991A1 (en) *	2007-11-02	2009-05-07	Biotrove, Inc.	Devices and methods for coupling mass spectrometry devices with chromatography systems
EP2670425A4 (en) *	2011-01-31	2015-07-01	Oklahoma Med Res Found	Ubiquitin interacting motif peptides as cancer therapeutics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5726025A (en) *	1995-04-20	1998-03-10	President And Fellows Of Harvard College	Assay and reagents for detecting inhibitors of ubiquitin-dependent degradation of cell cycle regulatory proteins
US5976849A (en) *	1998-02-05	1999-11-02	Zeneca Limited	Human E3 ubiquitin protein ligase
WO2001081584A2 (en) *	2000-04-25	2001-11-01	Millenium Pharmaceuticals, Inc.	27960, a novel ubiquitin conjugating enzyme family member and uses therefor
WO2002011750A2 (en) *	2000-08-08	2002-02-14	The Government Of The United States Of America, As Represented By The Secretary Of Health And Human	Prevention of beta-amyloid neurotoxicity by blockade of the ubiquitin-proteasome proteolytic pathway

2003
- 2003-11-04 WO PCT/US2003/035106 patent/WO2004041204A2/en not_active Application Discontinuation
- 2003-11-04 US US10/701,919 patent/US20040171085A1/en not_active Abandoned
- 2003-11-04 AU AU2003291730A patent/AU2003291730A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004041204A2 (en)	2004-05-21
WO2004041204A3 (en)	2006-05-11
AU2003291730A8 (en)	2004-06-07
US20040171085A1 (en)	2004-09-02

Similar Documents

Publication	Publication Date	Title
EP2671581B8 (en)	2019-11-13	Compositions and methods for treating cancer
AU2003230750A1 (en)	2003-10-13	Compositions and methods for treating cancer
WO2003073826A8 (en)	2005-04-28	Novel compositions and methods for cancer
AU2003252146A1 (en)	2004-06-23	Material compositions and related systems and methods for treating cardiac conditions
AUPS323902A0 (en)	2002-07-18	Compositions and methods for treating gynaecological disorders
AU2003225535A1 (en)	2003-09-02	Methods and compositions for treating cancer
AU2003271944A1 (en)	2004-05-13	Methods for making water treatment compositions and compositions thereof
AU2003287443A1 (en)	2004-05-25	Compositions and methods for pain reduction
AU2003268032A1 (en)	2004-02-16	Composition and methods for treatment and screening
AU2003291443A1 (en)	2004-06-03	Compositions and processes for nanoimprinting
AU2003297573A1 (en)	2004-06-23	Compositions and methods for treating transplants
AU2003232044A1 (en)	2003-11-17	Composition and method for dermatological treatment
AU2002235692A1 (en)	2002-09-04	Methods and compositions for preventing and treating neutrophil-mediated diseases
AU2002241343A1 (en)	2003-10-13	Decoy compositions for treating and preventing brain diseases and disorders
AU2003265842A1 (en)	2004-03-19	Anabaseine derivatives useful in the treatment of neurodegenerative diseases
AU2003219160A1 (en)	2004-09-30	Methods and compositions for the treatment of cancer
AU2003259833A1 (en)	2004-03-03	Methods of treating neurodegenerative diseases
AU2002322623A1 (en)	2004-02-09	Methods and compositions for treating diabetes mellitis
AU2003291730A1 (en)	2004-06-07	Methods and compositions for treating neurodegenerative diseases
AU2003237150A1 (en)	2003-11-17	Compositions and methods for treating inflammatory connective tissue diseases
AU2003298708A1 (en)	2004-06-23	GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER
AU2003214920A1 (en)	2003-09-02	Methods and compositions for treating hematological disorders
AU2003275433A1 (en)	2004-05-04	Compositions and methods for treating pain
AU2003278935A1 (en)	2004-04-19	Method and composition for treating neurodegenerative disorders
AU2003300171A1 (en)	2004-07-29	Compositions and methods for treating lung cancer

Legal Events

Date	Code	Title	Description
2005-07-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase